InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Guarini Kathryn. Director active across 1 company, notably Regeneron Pharmaceuticals, INC.. Aggregated, 8 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €570k. Activity tracked since 8 September 2023. The latest transaction was disclosed on 2 September 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Guarini Kathryn is a declarant linked to Regeneron Pharmaceuticals, INC. as Director. Across 6 filings in total, the 6 sampled filings cover the period from 2023-09-12 to 2026-08-12, with EUR 0 of buys and EUR 276896 of sells. The stated transaction nature is Attribution.